Abstract |
The preliminary results of a controlled study for treatment of 33 patients with squamous cell carcinoma of the head and neck region with regimen A: cis-DDP (3 mg/M2 dl) plus Bleomycin (15 mg/m2 i.v. continuously d2-6) against regimen B: Methotrexate (30 mg/m2 i.v. dl + 6) and vindesine (3 mg/m2 i.v. dl + 7) were as follows: complete remission (cr): 1 X A, 0 X B; partial remission (pr): 6 X A, 4 X B; minor response (mr): 3 X A, 7 X B; no change (nc): 2 X A, 0 X B; progression (pg): 5 X A, 5 X B. Due to progressive disease 8 patients were further treated with the alternative regimen with following results: cr: 1 X A; mr: 1 X A, 2 X B; nc: 1 X B; pg: 3 X A. Considering prognostic factors it could be demonstrated that primary chemotherapy (pc) was more effective that applied after operation and/or radiotherapy (secondary chemotherapy = sc): cr + pr: (= 53%), 4 X sc (= 22%); nc + pg: 1 X pc (= 7%), 7 X sc (= 39%).
|
Authors | H W von Heyden, J H Beyer, A Matthaei, G A Nagel, M Schröder |
Journal | Onkologie
(Onkologie)
Vol. 4
Issue 6
Pg. 296-9
(Dec 1981)
ISSN: 0378-584X [Print] Switzerland |
Vernacular Title | Zwischenauswertung einer Chemotherapie-Studie and Patienten mit Plattenepithelkarzinomen im Kopf-Hals-Bereich. Vergleich zweier Therapieregime: Cis-Diaminodichloroplatinum (II) (cis-DIP) und Pleomycin gegen Methotrexat und Vindesin. |
PMID | 6175933
(Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, English Abstract, Journal Article)
|
Chemical References |
- Antineoplastic Agents
- Bleomycin
- Vinblastine
- Cisplatin
- Vindesine
- Methotrexate
|
Topics |
- Adult
- Aged
- Antineoplastic Agents
(administration & dosage, therapeutic use)
- Bleomycin
(therapeutic use)
- Carcinoma, Squamous Cell
(drug therapy)
- Cisplatin
(therapeutic use)
- Drug Therapy, Combination
- Female
- Head and Neck Neoplasms
(drug therapy)
- Humans
- Male
- Methotrexate
(therapeutic use)
- Middle Aged
- Vinblastine
(analogs & derivatives, therapeutic use)
- Vindesine
|